Click here to subscribe to our newsletter |
|
|
Articles |
|
|
|
|
Rethinking Travel as Part of a Good Patient-Centric Clinical Trial
The landscape for clinical trials has seemingly been turned upside down with the onset of the COVID-19 pandemic. However, there is one factor that has remained crucial, and that is patient centricity
|
|
| |
|
|
Latest News & Press Releases |
|
|
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19
AGC Biologics has announced its partnership with Takara Bio. The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine, with AGC Biologics manufacturing...
|
|
|
|
|
| |
|
|
|
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio
GSK and Samsung Biologics have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK's innovative bio...
|
|
|
| |
| |
|
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
Novavax, Inc announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX CoV2373, a stable, prefusion protein made using its proprietary...
|
|
|
|
|
| |
|
|
|
Glenmark to Combine Two Anti-Viral Drugs; Start Trials on Indian COVID-19 Patients
Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in hospitalized patients of moderate...
|
|
|
| |
|
Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801
Merck and Ridgeback Biotherapeutics LP announced that the companies have entered into a collaboration agreement to develop EIDD-2801...
|
|
|
|
|
| |
|
|
|
AstraZeneca collaborates with ArcherDX to use personalised cancer assays to detect minimal residual disease in lung cancer trials
AstraZeneca will collaborate with ArcherDX, a genomic analysis company focused on precision oncology, to use personalised cancer monitoring...
|
|
|
| |
| |
|
Thermo Fisher Scientific Extends Collaboration with Biognosys to Enhance Protein Quantitation Mass Spectrometry Workflows
Thermo Fisher Scientific announce they are continuing their collaboration to advance DIA mass spectrometry-based workflows. Together, the companies have...
|
|
|
|
| |
|